secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2026-01-21T23:59:59+00:00
Accession:  0001213900-26-005779
Event type: other
Sentiment:  neutral
Materiality: 0.55
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD appoints CRI as new auditor; prior reports included going concern emphasis
--------------------------------------------------------------------------------

- Audit Committee approved CRI as independent auditor effective Jan 15, 2026; BPB dismissed.
- Change due to CRI acquiring certain assets of BPB's capital markets practice.
- No disagreements or reportable events with BPB during fiscal 2025 and 2024.
- BPB's reports for FY 2024 and 2023 included an explanatory paragraph on going concern uncertainty.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000121390026005779/0001213900-26-005779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000121390026005779/ea0273436-8k_therapeu.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-005779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer